Table 4.
Study | Model | All-Cause Mortality | Cardiovascular Events | Model Adjusted for |
---|---|---|---|---|
Weir et al10 | Adjusted RR | 1.4 (1.1-1.8) | 1.3 (0.9-2.0) | Matched patients from poorly dialyzable cohort to highly dialyzable cohort based on race, sex, and propensity scorea |
Shireman et al6 | Adjusted HR | 0.84 (0.72-0.97) | 0.86 (0.75-0.99) | Cardioselectivity, start of β-blocker, age, sex, race, BMI category, smoker status, substance use status, employment, inability of ambulate. Inability to transfer, diabetes, congestive heart failure, cerebrovascular accident, peripheral vascular disease, hemoglobin, self-care dialysis |
Assimon et al7 | Adjusted HR | 0.93 (0.86-0.98) | 0.85 (0.78-0.93) | Patient demographics, comorbid conditions, laboratory data, dialysis treatment parameters, and prescription medication use. Refer to Assimon et al7Table S2 for specifics |
Wu et al8 | Adjusted HR | 0.82 (0.75-0.88) | 0.89 (0.84-0.93) | Age, sex, comorbid conditions, concomitant medications |
Note: All-cause mortality and cardiovascular events hazard ratios and relative risks for highly dialyzable β-blockers versus poorly dialyzable β-blockers across the 4 studies. The average adjusted ratio was calculated using Review Manager.
Abbreviations: BMI, body mass index; HR, hazard ratio; IRR, incidence rate ratio; RR, risk ratio.
Weir et al10 matched their dialyzability cohorts based on the characteristics above instead of adjusting for the said characteristics.